is a congressionally mandated study of the Small Business Innovation Research (SBIR) Program, reviewing the operation and achievements of this $2.3 billion award program for small companies and start-ups. He is also directing a major study on best practice in global innovation programs, titled Comparative National Innovation Policies: Best Practice for the 21st Century. Today’s meeting “E Kamakani Noi’i” forms part of a complementary analysis entitled Competing in the 21st Century: Best Practice in State and Regional Innovation Initiatives. The overarching goal of Dr. Wessner’s work is to develop a better understanding of how we can bring new technologies forward to address global challenges in health, climate, energy, water, infrastructure, and security.
HANK C. K. WUH
An orthopedic surgeon, inventor, and entrepreneur, Dr. Hank C. K. Wuh has led the development of over twenty biomedical and consumer health care products from concept to global commercialization.
Dr. Wuh is founder and CEO of Skai Ventures, a hybrid of venture capital and technology accelerator focused on developing successful companies by transforming novel, ingenious ideas from scientists at leading universities into disruptive innovations. He is also founder and CEO of Cellular Bioengineering, Inc., developing the world’s most advanced, bioengineered cornea for transplantation to restore vision for the 10 million people around the world with corneal blindness (www.cellularbioengineering.com). Dr. Wuh recently founded World Children’s Vision, a charity with a mission to bring blind children from around the world to Hawaii for the gift of sight.
Skai Ventures’ portfolio companies include DeconGel® (www.decongel.com), a polymeric material for radiological, nuclear, and hazardous chemical remediation; TruTags (www.TruTags.com), an edible optical security platform targeting the $75 billion annual problem of pharmaceutical counterfeiting; International Center of Excellence for Vision, delivering leading-edge technology to restore sight for visually impaired patients from around the world; and StemPure, optimizing the safety of stem cell transplantation.
Dr. Wuh received his B.A. from Johns Hopkins, M.P.H. from Harvard, and M.D. from the Johns Hopkins School of Medicine. Dr. Wuh was resident and chief resident in orthopedic surgery at the Stanford Medical Center. He was elected class marshal at Harvard and was twice winner of the Vernon P. Thompson Prize for outstanding research in orthopedic surgery at Stanford. Dr. Wuh was named the 2008 Invention Entrepreneur of the Year by the Hawaii Venture Capital Association and was nominated in 2010 for The National Medal of Technology and Innovation.
At the University of Hawaii, Dr. Wuh is a member of the President’s Advisory Council on Innovation and Technology Advancement and the Dean’s Council at the School of Engineering, and he is associate clinical professor of